Top Markets
#1 DogBull DogBull +108.91%
#2 Siacoin Siacoin +62.85%
#3 MarsCoin MarsCoin +58.32%
#4 ADO Protocol ADO Protocol +52.87%
#5 The Bitcoin Bull The Bitcoin Bull +32.55%
#6 Ontology Gas Ontology Gas +24.65%
#7 Akedo Akedo +12.19%
#8 UnifAI Network UnifAI Network +11.92%
#9 Pons Pons +11.63%
#10 Velo Velo +10.71%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Rank in Stocks #15118
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Share Price
$4.74
Last synced: 2026-08-31
Market Cap
$372.19M
Change (1 day)
-2.47%
Change (1 year)
-1.04%
Country
US
Trade Lexeo Therapeutics, Inc. Common Stock (LXEO)

Category

Healthcare
Stock price history for Lexeo Therapeutics, Inc. Common Stock (LXEO)
Highest end of day price: $4.91 on 2026-08-01

Lowest end of day price: $11.06 on 2023-11-01
Stock price history of Lexeo Therapeutics, Inc. Common Stock from 2023 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -31.08%
2025 38.08%
2024 -48.79%
2023 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.37 -11.93%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $747.82 4.81%
CH